[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1262378, "exercisedValue": 0, "unexercisedValue": 18056}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 713958, "exercisedValue": 0, "unexercisedValue": 5625}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 696350, "exercisedValue": 0, "unexercisedValue": 4219}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Pinkosky", "title": "Vice President of Drug Discovery of Early Pre-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.42, "open": 1.39, "dayLow": 1.3435, "dayHigh": 1.42, "regularMarketPreviousClose": 1.42, "regularMarketOpen": 1.39, "regularMarketDayLow": 1.3435, "regularMarketDayHigh": 1.42, "payoutRatio": 0.0, "beta": 0.701, "forwardPE": 7.0, "volume": 2552999, "regularMarketVolume": 2552999, "averageVolume": 4871282, "averageVolume10days": 7208150, "averageDailyVolume10Day": 7208150, "bid": 1.02, "ask": 1.74, "bidSize": 2, "askSize": 2, "marketCap": 277478592, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 3.94, "priceToSalesTrailing12Months": 1.0689769, "fiftyDayAverage": 1.1382, "twoHundredDayAverage": 1.6678, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 756849216, "profitMargins": -0.59028, "floatShares": 196336387, "sharesOutstanding": 198199008, "sharesShort": 22097452, "sharesShortPriorMonth": 24113664, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.111499995, "heldPercentInsiders": 0.00567, "heldPercentInstitutions": 0.59402, "shortRatio": 7.25, "shortPercentOfFloat": 0.111999996, "impliedSharesOutstanding": 198199008, "bookValue": -2.167, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -153222000, "trailingEps": -0.85, "forwardEps": 0.2, "enterpriseToRevenue": 2.916, "enterpriseToEbitda": -18.962, "52WeekChange": -0.3364929, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 1.4, "targetHighPrice": 16.0, "targetLowPrice": 1.5, "targetMeanPrice": 5.78571, "targetMedianPrice": 4.0, "recommendationMean": 2.28571, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 114633000, "totalCashPerShare": 0.578, "ebitda": -39915000, "totalDebt": 594003008, "quickRatio": 0.723, "currentRatio": 1.176, "totalRevenue": 259574000, "revenuePerShare": 1.339, "returnOnAssets": -0.07166, "grossProfits": 124118000, "freeCashflow": -80851128, "operatingCashflow": -100110000, "revenueGrowth": -0.528, "grossMargins": 0.47816002, "ebitdaMargins": -0.15377, "operatingMargins": -0.33995998, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.40845, "regularMarketPrice": 1.4, "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "postMarketChangePercent": -0.021423612, "postMarketPrice": 1.3997, "postMarketChange": -0.00029993057, "regularMarketChange": -0.02, "regularMarketDayRange": "1.3435 - 1.42", "corporateActions": [], "postMarketTime": 1754092357, "regularMarketTime": 1754078401, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4871282, "fiftyTwoWeekLowChange": 0.71, "fiftyTwoWeekLowChangePercent": 1.0289855, "fiftyTwoWeekRange": "0.69 - 3.94", "fiftyTwoWeekHighChange": -2.54, "fiftyTwoWeekHighChangePercent": -0.64467, "fiftyTwoWeekChangePercent": -33.64929, "earningsTimestamp": 1754397000, "earningsTimestampStart": 1754397000, "earningsTimestampEnd": 1754397000, "earningsCallTimestampStart": 1754395200, "earningsCallTimestampEnd": 1754395200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.85, "epsForward": 0.2, "epsCurrentYear": -0.238, "priceEpsCurrentYear": -5.882353, "fiftyDayAverageChange": 0.26179993, "fiftyDayAverageChangePercent": 0.23001224, "twoHundredDayAverageChange": -0.26779997, "twoHundredDayAverageChangePercent": -0.1605708, "priceToBook": -0.64605445, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]